CommunicationNCT05812599
Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers
A study testing Educational Module in people with Communication and Health Knowledge, Attitudes, Practice, run by Washington University School of Medicine at 1 site in United States.
Trial summary
The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Communication, Health Knowledge, Attitudes, Practice
- What is being tested?
- Educational Module
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 298 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Sep 2022to 20 Jan 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Individuals who called 211 in Connecticut, Nebraska, or North Carolina on behalf of themselves or their families
- Must be 18 or older
- Must have English language proficiency
- Must be willing to be contacted via text messages or email
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country.
United States1 site
Washington University in St. Louis
St Louis, Missouri, 63130
About this study
Official title: Rapid Acceleration of Diagnostics Underserved Populations Supplement: Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers
The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.
- Being tested
- Educational Module
- Medical subject headings
- Communication, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational ModuleOther
The COVID Test Learning Module will present four multi-part character scenarios that someone might experience when considering testing for COVID-19. Participants will answer questions about the character's behavior. Accurate guidelines will be provided in response to each scenario to educate participants about what to do in nuanced COVID testing decision-making situations.
| Study group | Role | What they receive |
|---|---|---|
| COVID Test Learning Module | Experimental | In the experimental condition, participants will respond to survey questions (pre-exposure) before being presented with four narrative scenarios, questions, and accompanying messages about COVID testing (exposure), followed by post-test survey questions about COVID testing behaviors (post-exposure). Receives: Other: Educational Module |
| Control | No intervention | In the control condition, participants will respond to survey questions (pre-exposure) and post-test survey questions about COVID testing behaviors (post-exposure) only. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants who answer post-test questions correctly
The primary objective of this study is to evaluate differences in knowledge regarding COVID testing between 2-1-1 callers randomized to the control vs. experimental group. Participants who do better would answer more items correctly on the COVID prevention knowledge post-test. Assessed using a non-parametric t-test.
Measured: Through survey completion, an average of 10-15 minutes.
Secondary outcomes (1)
Number of participants with knowledge gained after exposure to learning module
A secondary outcome is to identify if exposure to the learning module increased participant knowledge about COVID prevention. Assessed by comparing the percentage of correct answers from questions within the learning module to the percentage of correct answers in the post-test.
Measured: Through survey completion, an average of 10-15 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2023
- Study start22 Sep 2022
- Primary completion20 Jan 2023
- Study completion20 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CommunicationStudies of the same condition, open and under way.
- More trials run by Washington University School of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 298 participants (actual)
Sponsor and investigators
- Lead sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Matthew Kreuter, Washington University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05812599
- Sponsor's protocol ID
- 3R01CA235773-03S1
- Status last verified
- Apr 2023
- First submitted
- 29 Nov 2022
- Last updated
- 13 Apr 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rapid Acceleration of Diagnostics Underserved Populations Supplement: Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers
- ClinicalTrials.gov ID
- NCT05812599
- Acronym / sponsor ID
- 3R01CA235773-03S1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 298 participants (actual)
- Lead sponsor
- Washington University School of MedicineUniversity, hospital or other
- Study start
- 22 Sep 2022 (actual)
- Primary completion
- 20 Jan 2023 (actual)
- Study completion
- 20 Jan 2023 (actual)
- First posted
- 13 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| COVID Test Learning Module | Experimental | Other: Educational ModuleIn the experimental condition, participants will respond to survey questions (pre-exposure) before being presented with four narrative scenarios, questions, and accompanying messages about COVID testing (exposure), followed by post-test survey questions about COVID testing behaviors (post-exposure). |
| Control | No intervention | –In the control condition, participants will respond to survey questions (pre-exposure) and post-test survey questions about COVID testing behaviors (post-exposure) only. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Individuals who called 211 in Connecticut, Nebraska, or North Carolina on behalf of themselves or their families
- Must be 18 or older
- Must have English language proficiency
- Must be willing to be contacted via text messages or email
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational ModuleThe COVID Test Learning Module will present four multi-part character scenarios that someone might experience when considering testing for COVID-19. Participants will answer questions about the character's behavior. Accurate guidelines will be provided in response to each scenario to educate participants about what to do in nuanced COVID testing decision-making situations. | Other | COVID Test Learning Module |
Primary outcome
Proportion of participants who answer post-test questions correctly
Time frame: Through survey completion, an average of 10-15 minutes.
The primary objective of this study is to evaluate differences in knowledge regarding COVID testing between 2-1-1 callers randomized to the control vs. experimental group. Participants who do better would answer more items correctly on the COVID prevention knowledge post-test. Assessed using a non-parametric t-test.
1 secondary outcome
Number of participants with knowledge gained after exposure to learning module
Time frame: Through survey completion, an average of 10-15 minutes.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Communication
Recruiting
Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter
Stuttering, Fluency Disorder
Recruiting
Vowel Space Expansion Sensorimotor Adaptation
Speech
RecruitingObservational study
Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
Aphasia, Stroke
RecruitingObservational study
Speech and Language Interventions for Italian People With PPA
Primary Progressive Aphasia(PPA)
Recruiting
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
Brainstem Stroke, ALS
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational Module in people with Communication and Health Knowledge, Attitudes, Practice, run by Washington University School of Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants who answer post-test questions correctly (time frame: Through survey completion, an average of 10-15 minutes.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2023.